Literature DB >> 15934310

Preparation and acute toxicology of nano-magnetic ferrofluid.

Zefeng Xia1, Guobin Wang, Kaixiong Tao, Jianxing Li, Yuan Tian.   

Abstract

The nano-magnetic ferrofluid was prepared by chemical coprecipitation and its acute toxicology was investigated. The effective diameter (Eff. Diam. ) of the magnetic particles was about 19.9 nm, and the concentration of the ferrofluid was 17. 54 mg/ml. The acute toxic reaction and the main viscera pathological morphology of mice were evaluated after oral, intravenous and intraperitoneal administration of the nano-magnetic ferrofluid of different doses respectively. Half lethal dose (LD50) > 2104. 8 mg/kg,maximum non-effect dose (ED0) = 320. 10mg/kg with oral; LDs,> 438. 50 mg/kg, EDo = 160. 05 mg/kg with intravenous route; and LDso >1578. 6 mg/kg, ED0 = 320. 10 mg/kg with intraperitoneal administration. Degeneration and necrosis of viscera were not found. So the nano-magnetic ferrofluid, of which toxicity is very low, may be used as a drug carrier.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15934310     DOI: 10.1007/BF02831388

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

1.  Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization.

Authors:  Susanne Wagner; Jorg Schnorr; Herbert Pilgrimm; Bernd Hamm; Matthias Taupitz
Journal:  Invest Radiol       Date:  2002-04       Impact factor: 6.016

Review 2.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue.

Authors:  Jayanth Panyam; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2003-02-24       Impact factor: 15.470

3.  Overview of contrast enhancement with iron oxides.

Authors:  G Frija; O Clément; E de Kerviler
Journal:  Invest Radiol       Date:  1994-06       Impact factor: 6.016

4.  Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier.

Authors:  S C Goodwin; C A Bittner; C L Peterson; G Wong
Journal:  Toxicol Sci       Date:  2001-03       Impact factor: 4.849

5.  Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer.

Authors:  H Iinuma; K Okinaga; M Adachi; K Suda; T Sekine; K Sakagawa; Y Baba; J Tamura; H Kumagai; A Ida
Journal:  Int J Cancer       Date:  2000-07-20       Impact factor: 7.396

6.  Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.

Authors:  A Jordan; R Scholz; P Wust; H Fähling; J Krause; W Wlodarczyk; B Sander; T Vogl; R Felix
Journal:  Int J Hyperthermia       Date:  1997 Nov-Dec       Impact factor: 3.914

7.  Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.

Authors:  A S Lübbe; C Bergemann; H Riess; F Schriever; P Reichardt; K Possinger; M Matthias; B Dörken; F Herrmann; R Gürtler; P Hohenberger; N Haas; R Sohr; B Sander; A J Lemke; D Ohlendorf; W Huhnt; D Huhn
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

8.  Magnetic iron oxide particles coated with carboxydextran for parenteral administration and liver contrasting. Pre-clinical profile of SH U555A.

Authors:  R Lawaczeck; H Bauer; T Frenzel; M Hasegawa; Y Ito; K Kito; N Miwa; H Tsutsui; H Vogler; H J Weinmann
Journal:  Acta Radiol       Date:  1997-07       Impact factor: 1.990

  8 in total
  2 in total

1.  Ferrofluid-associated Cutaneous Dyschromia: Discoloration of Hand and Fingers Following Accidental Exposure to Ferromagnetic Fluid.

Authors:  Philip R Cohen; Kenneth S Arfa
Journal:  J Clin Aesthet Dermatol       Date:  2016-03-01

2.  Acute phase pulmonary responses to a single intratracheal spray instillation of magnetite (fe(3)o(4)) nanoparticles in Fischer 344 rats.

Authors:  Yukie Tada; Norio Yano; Hiroshi Takahashi; Katsuhiro Yuzawa; Hiroshi Ando; Yoshikazu Kubo; Akemichi Nagasawa; Akio Ogata; Dai Nakae
Journal:  J Toxicol Pathol       Date:  2012-12-20       Impact factor: 1.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.